Top Page | English | 简体中文 | 繁體中文 | 한국어 | 日本語
Friday, 24 April 2020, 16:00 HKT/SGT
Share:
    

Source: Shinsung TK Co., Ltd.
Shinsung TK Participates in 'Arab Health 2020', the Largest Medical Device Exhibition in the Middle East

GWANGJU, KOREA, Apr 24, 2020 - (ACN Newswire) - Shinsung TK Co., Ltd., a company specializing in IoT-based healthcare systems, participated in the 45th Dubai International Medical Equipment Exhibition (Arab Health 2020) at the Dubai World Trade Center, from January 27 to 30 this year. Arab Health, representing more than 159 countries, is an international medical exhibition that provides businesses with various opportunities to reach new and potential customers from around the world.


During the exhibition, Shinsung TK held meetings with 45 companies at its booth, identifying the needs of investors and understanding the market of each country. Not only was the technological excellence of its IoT-based iRINGER IV Infusion Monitoring System universally recognized, but Shinsung TK affirmed its potential as a partner as well, having collaborated with various companies around the world and playing a major role in technology development.

iRINGER, a smart Infusion Monitoring System, automatically calculates the amount and speed (cc/hr) of the infusion, and uses wireless technology to inform nurses and medical personnel outside the hospital ward via smartphone or PC web. It also provides an alarm (sound and vibration) through a smart call (automatic transmission) when an anomaly occurs.

Shinsung TK has been participating in the health care exhibition annually since 2016, promoting its product technology continuously to establish its position in the overseas medical market. Recently, the use of iRINGER has increased as issues of non-face-to-face treatment following the coronavirus became significant.

Eunseop Lim, the CEO of Shinsung TK, said "Based on our IoT remote infusion monitoring technology, which is the result of continuous technology investment and innovation, the company plans to expand its smart healthcare platform technology in the future to measures not only the infusion, but also the patient's body temperature and pulse, temperature and humidity, and urine volume."

Shinsung TK signed an MOU agreement with the Malaysian company LKL in 2019. It will participate in the Medicine 4.0 conference with LKL at Malaysia's Matrade Convention Center for two days from August 8th - 9th 2020 to showcase its technology.

Media contact
SHINSUNG TK Co., Ltd.
Contact: Eun Suab Lim
Email: sstop77@shinsungtk.com
Phone: +82-62-972-0629
Website: http://shinsungtk.com/en/



Topic: New market for product
Source: Shinsung TK Co., Ltd.

Sectors: Healthcare & Pharm
http://www.acnnewswire.com
From the Asia Corporate News Network


Copyright © 2026 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.



Latest Press Releases
Everest Medicines Announces Commercial Launch and First Prescription for VELSIPITY(R) in Mainland China, Addressing Unmet Need in Moderately to Severely Active Ulcerative Colitis  
Thursday, March 12, 2026 12:50:00 PM
Yuexiu REIT Maintains Operational Resilience, Revenue Exceeds RMB1.8 Billion in 2025  
Mar 12, 2026 12:42 HKT/SGT
Axonex Intelligence and Synergy Technology Group Form Joint Venture to Accelerate Digital Twin and Drone Flight Control Expansion  
Mar 12, 2026 11:43 HKT/SGT
NEC and The University of Tokyo calculate carbon accumulation rates in Malaysian national park with a 9.4% margin of error  
Thursday, March 12, 2026 11:02:00 AM
More than 1,000 top buyers to attend! Procurement opportunities at China Chaoshan International Textile and Garment Exhibition  
Mar 12, 2026 11:00 HKT/SGT
Japantastics Introduces the World of Kodaimoji, Bringing Ancient Characters into Modern Spaces  
Thursday, March 12, 2026 10:00:00 AM
Tenstorrent Unveils TT-QuietBox(TM) 2, the First RISC-V AI Workstation With a Fully Open-Source Stack to Deliver Teraflop-Class Inference  
Mar 12, 2026 00:00 HKT/SGT
MarketingPulse and eTailingPulse open next Thursday  
Mar 11, 2026 16:54 HKT/SGT
Eisai to Present the Latest Data on Long-Term, Real-World Treatment with Lecanemab at the AD/PD(TM) 2026 Annual Meeting   
Wednesday, March 11, 2026 11:07:00 AM
JOYY Reports 4Q and FY2025 Financial Results: Q4 Revenue Returns to YoY Growth, BIGO Ads Up 61.5% YoY  
Mar 11, 2026 09:40 HKT/SGT
More Press release >>
 Events:
More >>
 News Alerts
Copyright © 2026 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 214 890 4418 | China: +86 181 2376 3721 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575

Connect With us: